We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.07%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$1.62B
AUM Growth
+$83.9M
Cap. Flow
-$21.9M
Cap. Flow %
-1.36%
Top 10 Hldgs %
35.16%
Holding
2,764
New
163
Increased
787
Reduced
971
Closed
110

Sector Composition

Rank Sector Weight
1 Technology 13.57%
2 Financials 7.54%
3 Healthcare 6.16%
4 Consumer Discretionary 5.27%
5 Communication Services 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAPO
2351
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$2K ﹤0.01%
9
QUOT
2352
DELISTED
Quotient Technology Inc
QUOT
$2K ﹤0.01%
210
LSI
2353
DELISTED
Life Storage, Inc.
LSI
$2K ﹤0.01%
24
SJI
2354
DELISTED
South Jersey Industries, Inc.
SJI
$2K ﹤0.01%
91
+46
+102% +$1.03K
CCXI
2355
DELISTED
ChemoCentryx, Inc.
CCXI
$2K ﹤0.01%
35
+5
+17% +$269
CVET
2356
DELISTED
Covetrus, Inc. Common Stock
CVET
$2K ﹤0.01%
68
ACC
2357
DELISTED
American Campus Communities, Inc.
ACC
$2K ﹤0.01%
64
+4
+7% +$138
VRS
2358
DELISTED
Verso Corporation
VRS
$2K ﹤0.01%
233
-251
-52% -$3.05K
MGLN
2359
DELISTED
Magellan Health Services, Inc.
MGLN
$2K ﹤0.01%
22
CXP
2360
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$2K ﹤0.01%
147
-69
-32% -$823
DSPG
2361
DELISTED
DSP Group Inc
DSPG
$2K ﹤0.01%
151
+141
+1,410% +$2.07K
TBIO
2362
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$2K ﹤0.01%
137
BPY
2363
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$2K ﹤0.01%
200
CBMG
2364
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$2K ﹤0.01%
121
+109
+908% +$1.83K
CLCT
2365
DELISTED
Collectors Universe
CLCT
$2K ﹤0.01%
+49
New +$2.1K
IMMU
2366
DELISTED
Immunomedics Inc
IMMU
$2K ﹤0.01%
+25
New +$1.26K
ZMLP
2367
DELISTED
Direxion Zacks MLP High Income Index Shares
ZMLP
$2K ﹤0.01%
45
DLPH
2368
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$2K ﹤0.01%
121
GTT
2369
DELISTED
GTT Communications, Inc.
GTT
$2K ﹤0.01%
+322
New +$1.93K
PDLI
2370
DELISTED
PDL BioPharma, Inc.
PDLI
$2K ﹤0.01%
+681
New +$2.17K
ADEA icon
2371
Adeia
ADEA
$3.11B
$1K ﹤0.01%
291
-1,421
-83% -$5.25K
AIR icon
2372
AAR Corp
AIR
$5.76B
$1K ﹤0.01%
65
AKR icon
2373
Acadia Realty Trust
AKR
$2.84B
$1K ﹤0.01%
91
-54
-37% -$645
ALLT icon
2374
Allot
ALLT
$383M
$1K ﹤0.01%
152
ALX
2375
Alexander's
ALX
$1.41B
$1K ﹤0.01%
+4
New +$1.01K

Similar funds

Parallel Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Parallel Advisors held 2,764 positions worth $1.62B, up 5.5% from $1.53B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors's Q3 2020 filing shows 163 new, 787 increased, 971 reduced and 110 closed positions. Its largest new stake was 1Life Healthcare: 297,796 shares worth $8.45M. The largest sale was Microsoft, an estimated $26.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

  • Parallel Advisors's largest Q3 2020 buy was 1Life Healthcare: 297,796 shares worth $8.45M.
  • Parallel Advisors added most to iShares US Treasury Bond ETF in Q3 2020, an estimated $20M increase.
  • Parallel Advisors's biggest Q3 2020 reduction was Microsoft, cutting an estimated $26.7M.
  • Parallel Advisors fully exited Medallia, Inc. in Q3 2020, selling an estimated $851K.
  • Parallel Advisors's ten largest holdings make up 35% of its $1.62B portfolio in Q3 2020.
  • Parallel Advisors opened 163 new positions and closed 110 in Q3 2020.
  • Parallel Advisors's portfolio value rose 5.5% quarter-over-quarter to $1.62B.

Based on Parallel Advisors's 13F filing for Q3 2020, filed 27 Oct 2020.